ArQule (ARQL) Jumps: Stock Rises 6.8%

ArQule Inc. (NASD:ARQL) was a big mover last session, as the company saw its shares rise by roughly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock has now gained roughly 24% in the past one month time frame.

This biotechnology company has seen no estimate revision over the past 30 days and its Zacks Consensus Estimate remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

ArQule currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the healthcare sector include Endocyte, Inc. (NASD:ECYT), Grifols, S.A. (NASD:GRFS) and Lannett Company, Inc. (NYSE:LCI). All these stocks hold a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>




ARQULE INC (ARQL): Free Stock Analysis Report

ENDOCYTE INC (ECYT): Free Stock Analysis Report

GRIFOLS SA ADS (GRFS): Free Stock Analysis Report

LANNETT COMP (LCI): Free Stock Analysis Report


Zacks Investment Research

Advertisement